|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:SLC2A1-ATN1 (FusionGDB2 ID:82224) |
Fusion Gene Summary for SLC2A1-ATN1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: SLC2A1-ATN1 | Fusion gene ID: 82224 | Hgene | Tgene | Gene symbol | SLC2A1 | ATN1 | Gene ID | 6513 | 1822 |
Gene name | solute carrier family 2 member 1 | atrophin 1 | |
Synonyms | CSE|DYT17|DYT18|DYT9|EIG12|GLUT|GLUT-1|GLUT1|GLUT1DS|HTLVR|PED|SDCHCN | B37|CHEDDA|D12S755E|DRPLA|HRS|NOD | |
Cytomap | 1p34.2 | 12p13.31 | |
Type of gene | protein-coding | protein-coding | |
Description | solute carrier family 2, facilitated glucose transporter member 1choreoathetosis/spasticity, episodic (paroxysmal choreoathetosis/spasticity)glucose transporter type 1, erythrocyte/brainhepG2 glucose transporterhuman T-cell leukemia virus (I and II) r | atrophin-1dentatorubral-pallidoluysian atrophy protein | |
Modification date | 20200322 | 20200313 | |
UniProtAcc | . | P54259 | |
Ensembl transtripts involved in fusion gene | ENST00000426263, ENST00000475162, ENST00000415851, ENST00000372500, | ENST00000356654, ENST00000396684, | |
Fusion gene scores | * DoF score | 8 X 6 X 6=288 | 10 X 10 X 2=200 |
# samples | 8 | 10 | |
** MAII score | log2(8/288*10)=-1.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/200*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: SLC2A1 [Title/Abstract] AND ATN1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | SLC2A1(43406854)-ATN1(7047828), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | SLC2A1 | GO:0065003 | protein-containing complex assembly | 18347014 |
Hgene | SLC2A1 | GO:1904659 | glucose transmembrane transport | 2211693|18245775|25982116|27078104 |
Tgene | ATN1 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 10973986 |
Tgene | ATN1 | GO:0051402 | neuron apoptotic process | 10085113 |
Fusion gene breakpoints across SLC2A1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ATN1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS5.0 | N/A | AW352237 | SLC2A1 | chr1 | 43406854 | - | ATN1 | chr12 | 7047828 | - |
Top |
Fusion Gene ORF analysis for SLC2A1-ATN1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000426263 | ENST00000356654 | SLC2A1 | chr1 | 43406854 | - | ATN1 | chr12 | 7047828 | - |
intron-3CDS | ENST00000426263 | ENST00000396684 | SLC2A1 | chr1 | 43406854 | - | ATN1 | chr12 | 7047828 | - |
intron-3CDS | ENST00000475162 | ENST00000356654 | SLC2A1 | chr1 | 43406854 | - | ATN1 | chr12 | 7047828 | - |
intron-3CDS | ENST00000475162 | ENST00000396684 | SLC2A1 | chr1 | 43406854 | - | ATN1 | chr12 | 7047828 | - |
intron-3CDS | ENST00000415851 | ENST00000356654 | SLC2A1 | chr1 | 43406854 | - | ATN1 | chr12 | 7047828 | - |
intron-3CDS | ENST00000415851 | ENST00000396684 | SLC2A1 | chr1 | 43406854 | - | ATN1 | chr12 | 7047828 | - |
intron-3CDS | ENST00000372500 | ENST00000356654 | SLC2A1 | chr1 | 43406854 | - | ATN1 | chr12 | 7047828 | - |
intron-3CDS | ENST00000372500 | ENST00000396684 | SLC2A1 | chr1 | 43406854 | - | ATN1 | chr12 | 7047828 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for SLC2A1-ATN1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for SLC2A1-ATN1 |
Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | ATN1 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Transcriptional corepressor. Recruits NR2E1 to repress transcription. Promotes vascular smooth cell (VSMC) migration and orientation (By similarity). Corepressor of MTG8 transcriptional repression. Has some intrinsic repression activity which is independent of the number of poly-Gln (polyQ) repeats. {ECO:0000250|UniProtKB:O35126, ECO:0000269|PubMed:10085113, ECO:0000269|PubMed:10973986}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for SLC2A1-ATN1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for SLC2A1-ATN1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for SLC2A1-ATN1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for SLC2A1-ATN1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SLC2A1 | C4551966 | GLUT1 DEFICIENCY SYNDROME 1 | 25 | CLINGEN;GENOMICS_ENGLAND;UNIPROT |
Hgene | SLC2A1 | C1842534 | DYSTONIA 18 (disorder) | 15 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | SLC2A1 | C1847501 | Glut1 Deficiency Syndrome | 12 | CLINGEN;CTD_human;ORPHANET |
Hgene | SLC2A1 | C3149117 | GLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE | 8 | CLINGEN |
Hgene | SLC2A1 | C3553859 | EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12 | 6 | GENOMICS_ENGLAND;UNIPROT |
Hgene | SLC2A1 | C0036572 | Seizures | 4 | CTD_human;GENOMICS_ENGLAND |
Hgene | SLC2A1 | C0008073 | Developmental Disabilities | 3 | CTD_human |
Hgene | SLC2A1 | C0013421 | Dystonia | 3 | GENOMICS_ENGLAND |
Hgene | SLC2A1 | C0022333 | Jacksonian Seizure | 3 | CTD_human |
Hgene | SLC2A1 | C0085996 | Child Development Deviations | 3 | CTD_human |
Hgene | SLC2A1 | C0085997 | Child Development Disorders, Specific | 3 | CTD_human |
Hgene | SLC2A1 | C0149958 | Complex partial seizures | 3 | CTD_human |
Hgene | SLC2A1 | C0234533 | Generalized seizures | 3 | CTD_human |
Hgene | SLC2A1 | C0234535 | Clonic Seizures | 3 | CTD_human |
Hgene | SLC2A1 | C0270824 | Visual seizure | 3 | CTD_human |
Hgene | SLC2A1 | C0270844 | Tonic Seizures | 3 | CTD_human |
Hgene | SLC2A1 | C0270846 | Epileptic drop attack | 3 | CTD_human |
Hgene | SLC2A1 | C0422850 | Seizures, Somatosensory | 3 | CTD_human |
Hgene | SLC2A1 | C0422852 | Seizures, Auditory | 3 | CTD_human |
Hgene | SLC2A1 | C0422853 | Olfactory seizure | 3 | CTD_human |
Hgene | SLC2A1 | C0422854 | Gustatory seizure | 3 | CTD_human |
Hgene | SLC2A1 | C0422855 | Vertiginous seizure | 3 | CTD_human |
Hgene | SLC2A1 | C0494475 | Tonic - clonic seizures | 3 | CTD_human |
Hgene | SLC2A1 | C0751056 | Non-epileptic convulsion | 3 | CTD_human |
Hgene | SLC2A1 | C0751110 | Single Seizure | 3 | CTD_human |
Hgene | SLC2A1 | C0751123 | Atonic Absence Seizures | 3 | CTD_human |
Hgene | SLC2A1 | C0751494 | Convulsive Seizures | 3 | CTD_human |
Hgene | SLC2A1 | C0751495 | Seizures, Focal | 3 | CTD_human |
Hgene | SLC2A1 | C0751496 | Seizures, Sensory | 3 | CTD_human |
Hgene | SLC2A1 | C1832855 | CHOREOATHETOSIS/SPASTICITY, EPISODIC | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | SLC2A1 | C1837206 | Cryohydrocytosis, Stomatin-Deficient, with Mental Retardation, Seizures, Cataracts, and Massive Hepatosplenomegaly | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | SLC2A1 | C3495874 | Nonepileptic Seizures | 3 | CTD_human |
Hgene | SLC2A1 | C4048158 | Convulsions | 3 | CTD_human |
Hgene | SLC2A1 | C4316903 | Absence Seizures | 3 | CTD_human |
Hgene | SLC2A1 | C4317109 | Epileptic Seizures | 3 | CTD_human |
Hgene | SLC2A1 | C4317123 | Myoclonic Seizures | 3 | CTD_human |
Hgene | SLC2A1 | C4505436 | Generalized Absence Seizures | 3 | CTD_human |
Hgene | SLC2A1 | C0025958 | Microcephaly | 2 | CTD_human |
Hgene | SLC2A1 | C0270850 | Idiopathic generalized epilepsy | 2 | GENOMICS_ENGLAND |
Hgene | SLC2A1 | C0272048 | stomatocytic anemia | 2 | GENOMICS_ENGLAND |
Hgene | SLC2A1 | C0677598 | Stomatocytosis Result | 2 | GENOMICS_ENGLAND |
Hgene | SLC2A1 | C1838604 | EPILEPSY, CHILDHOOD ABSENCE, 1 | 2 | ORPHANET |
Hgene | SLC2A1 | C1956147 | Microlissencephaly | 2 | CTD_human |
Hgene | SLC2A1 | C3714756 | Intellectual Disability | 2 | CTD_human;GENOMICS_ENGLAND |
Hgene | SLC2A1 | C3853041 | Severe Congenital Microcephaly | 2 | CTD_human |
Hgene | SLC2A1 | C0004134 | Ataxia | 1 | CTD_human |
Hgene | SLC2A1 | C0004138 | Ataxias, Hereditary | 1 | GENOMICS_ENGLAND |
Hgene | SLC2A1 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Hgene | SLC2A1 | C0007102 | Malignant tumor of colon | 1 | CTD_human |
Hgene | SLC2A1 | C0007124 | Noninfiltrating Intraductal Carcinoma | 1 | CTD_human |
Hgene | SLC2A1 | C0007134 | Renal Cell Carcinoma | 1 | CTD_human |
Hgene | SLC2A1 | C0007621 | Neoplastic Cell Transformation | 1 | CTD_human |
Hgene | SLC2A1 | C0009375 | Colonic Neoplasms | 1 | CTD_human |
Hgene | SLC2A1 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
Hgene | SLC2A1 | C0020796 | Profound Mental Retardation | 1 | CTD_human |
Hgene | SLC2A1 | C0023903 | Liver neoplasms | 1 | CTD_human |
Hgene | SLC2A1 | C0025363 | Mental Retardation, Psychosocial | 1 | CTD_human |
Hgene | SLC2A1 | C0025521 | Inborn Errors of Metabolism | 1 | CTD_human |
Hgene | SLC2A1 | C0027125 | Myotonia | 1 | GENOMICS_ENGLAND |
Hgene | SLC2A1 | C0027765 | nervous system disorder | 1 | CTD_human |
Hgene | SLC2A1 | C0029408 | Degenerative polyarthritis | 1 | CTD_human |
Hgene | SLC2A1 | C0031149 | Peritoneal Neoplasms | 1 | CTD_human |
Hgene | SLC2A1 | C0037772 | Spastic Paraplegia | 1 | GENOMICS_ENGLAND |
Hgene | SLC2A1 | C0086543 | Cataract | 1 | GENOMICS_ENGLAND |
Hgene | SLC2A1 | C0086743 | Osteoarthrosis Deformans | 1 | CTD_human |
Hgene | SLC2A1 | C0240991 | Ataxia, Sensory | 1 | CTD_human |
Hgene | SLC2A1 | C0278161 | Ataxia, Motor | 1 | CTD_human |
Hgene | SLC2A1 | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 1 | CTD_human |
Hgene | SLC2A1 | C0345904 | Malignant neoplasm of liver | 1 | CTD_human |
Hgene | SLC2A1 | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Hgene | SLC2A1 | C0346990 | Carcinomatosis of peritoneal cavity | 1 | CTD_human |
Hgene | SLC2A1 | C0424605 | Developmental delay (disorder) | 1 | GENOMICS_ENGLAND |
Hgene | SLC2A1 | C0427190 | Ataxia, Truncal | 1 | CTD_human |
Hgene | SLC2A1 | C0520966 | Abnormal coordination | 1 | CTD_human |
Hgene | SLC2A1 | C0543888 | Epileptic encephalopathy | 1 | GENOMICS_ENGLAND |
Hgene | SLC2A1 | C0557874 | Global developmental delay | 1 | GENOMICS_ENGLAND |
Hgene | SLC2A1 | C0678222 | Breast Carcinoma | 1 | CTD_human |
Hgene | SLC2A1 | C0750937 | Ataxia, Appendicular | 1 | CTD_human |
Hgene | SLC2A1 | C0750940 | Tremor, Rubral | 1 | CTD_human |
Hgene | SLC2A1 | C0917816 | Mental deficiency | 1 | CTD_human |
Hgene | SLC2A1 | C0919267 | ovarian neoplasm | 1 | CTD_human |
Hgene | SLC2A1 | C1140680 | Malignant neoplasm of ovary | 1 | CTD_human |
Hgene | SLC2A1 | C1176475 | Ductal Carcinoma | 1 | CTD_human |
Hgene | SLC2A1 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Hgene | SLC2A1 | C1266042 | Chromophobe Renal Cell Carcinoma | 1 | CTD_human |
Hgene | SLC2A1 | C1266043 | Sarcomatoid Renal Cell Carcinoma | 1 | CTD_human |
Hgene | SLC2A1 | C1266044 | Collecting Duct Carcinoma of the Kidney | 1 | CTD_human |
Hgene | SLC2A1 | C1306837 | Papillary Renal Cell Carcinoma | 1 | CTD_human |
Hgene | SLC2A1 | C1332347 | Atypical Ductal Breast Hyperplasia | 1 | CTD_human |
Hgene | SLC2A1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Hgene | SLC2A1 | C1851936 | Paroxysmal choreoathetosis | 1 | GENOMICS_ENGLAND |
Hgene | SLC2A1 | C1869117 | Paroxysmal nonkinesigenic dyskinesia | 1 | GENOMICS_ENGLAND |
Hgene | SLC2A1 | C2239176 | Liver carcinoma | 1 | CTD_human |
Hgene | SLC2A1 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
Tgene | ATN1 | C0008925 | Cleft Palate | 1 | GENOMICS_ENGLAND |
Tgene | ATN1 | C0036572 | Seizures | 1 | GENOMICS_ENGLAND |
Tgene | ATN1 | C0232466 | Feeding difficulties | 1 | GENOMICS_ENGLAND |
Tgene | ATN1 | C0243050 | Cardiovascular Abnormalities | 1 | GENOMICS_ENGLAND |
Tgene | ATN1 | C0266292 | Congenital anomaly of the kidney | 1 | GENOMICS_ENGLAND |
Tgene | ATN1 | C0557874 | Global developmental delay | 1 | GENOMICS_ENGLAND |
Tgene | ATN1 | C1858120 | Generalized hypotonia | 1 | GENOMICS_ENGLAND |
Tgene | ATN1 | C3714756 | Intellectual Disability | 1 | GENOMICS_ENGLAND |